Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics

Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics

TechCrunch

Published

Psychedelics companies are all the rage right now. Compass Pathways is working with the magic mushroom compound psilocybin to treat depression. It’s has raised $290 million in total. Atai Life Sciences — backed by PayPal co-founder Peter Thiel — brought in $258 million from its IPO. In the tech space, this has not gone unnoticed […]

Full Article